<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biomedical and Pharmacology Journal</journalTitle>
          <issn>0974-6242</issn>
            <publicationDate>2026-11-06</publicationDate>
    
        <volume>19</volume>
        <issue>4</issue>

 
    <startPage></startPage>
    <endPage></endPage>

	    <publisherRecordId>73884</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Experimental Animal Models in Immunomodulatory Research: A Preclinical Viewpoint</title>

    <authors>
	 


      <author>
       <name>Anuradha Kalita</name>

 
		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name>Manas Das</name>


		
	<affiliationId>2</affiliationId>

      </author>
    

	

	


	


	
    </authors>
    
	    <affiliationsList>
	    
		
		<affiliationName affiliationId="1">Department of Zoology, Handique Girls’ College, Guwahati, Assam, India </affiliationName>
    

		
		<affiliationName affiliationId="2">Department of Zoology, Gauhati University, Guwahati, Assam, India </affiliationName>
    
		
		
		
		
	  </affiliationsList>






    <abstract language="eng">Immunomodulation is a vital therapeutic approach for various illnesses, including as cancer, autoimmune diseases, infectious diseases, and hypersensitivity, is immunomodulation, or the deliberate alteration of the immune response. Experimental animal models are still essential for comprehending intricate systemic immune responses and assessing the effectiveness of synthetic and plant-derived medications before they are used in clinical settings, while <em>in vitro</em> systems provide mechanistic insights. A thorough search of PubMed, Scopus, and Web of Science was carried out. This review assesses animal models in immunomodulatory research. In order to bridge the gap between preclinical research and human clinical trials, the study compares the model fidelity, immunological markers, and translational success rates of murine, porcine, and non-human primate models. The results show a strategic duality in immunomodulation: immunostimulatory approaches are necessary for immunodeficiencies and cancer, while immunosuppressive strategies are necessary for autoimmunity and graft rejection. The cost-effectiveness and genetic manipulability of rodent models, such as C57BL/6 and BALB/c, make them popular, yet their Th1/Th2 cytokine profiles often differ from those of humans. On the other hand, cytokine release syndrome predictive value is 40% higher in humanized mice models (hNSG). Additionally, investigations on mucosal immunity and transplantation benefit greatly from the superior physiological relevance of big animal models, especially pigs. The use of "dirty" mice (feral or pet-store) to more closely mimic the immunological experience of an adult human is becoming more and more popular. A careful balance between biological relevance and experimental throughput is required when choosing an appropriate animal model. Overcoming the "valley of death" in translational immunology requires a multi-model strategy that integrates humanized systems and possibly "Organs-on-a-chip," as this paper highlights. In the end, these models are crucial for preclinical evaluation of novel treatments in a range of pathophysiological contexts.</abstract>

    <fullTextUrl format="html">https://biomedpharmajournal.org/vol19no4/experimental-animal-models-in-immunomodulatory-research-a-preclinical-viewpoint/</fullTextUrl>

<keywords language="eng">

      
        <keyword>Animal models</keyword>
      

      
        <keyword> Humanized mice</keyword>
      

      
        <keyword> Immunomodulation</keyword>
      

      
        <keyword> Immunotherapy</keyword>
      

      
        <keyword> Immunodeficiency</keyword>
      

      
        <keyword> Preclinical assessment</keyword>
      

      
        <keyword> Translational research</keyword>
      
</keywords>
  </record>
</records>